GlassScriptPhysician profile
Arashk Motiei
NPI 1225000748
$1,334.80
in general payments reported to CMS, 2019-2025
13 companies · $73.75 in 2025
The $73.75 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $287 · 2020: $115 · 2021: $64.20 · 2022: $287 · 2023: $59.42 · 2024: $449 · 2025: $73.75.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $582.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $581.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $235.07 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Biotronik INC. | $234.27 | 2019-2024 | Passeo-18, Pulsar-18 T3 |
| Medtronic, INC. | $214.04 | 2022-2023 | Hawkone |
| Penumbra, INC. | $159.97 | 2019-2022 | |
| Abiomed | $119.24 | 2019 | |
| Terumo Medical Corporation | $115.08 | 2020 | |
| Angiodynamics, INC. | $102.68 | 2024 | Angiovac |
| Stryker Corporation | $73.75 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Bard Peripheral Vascular, INC. | $34.47 | 2021 | |
| Shockwave Medical, INC | $18.56 | 2021 | |
| Silk Road Medical, INC. | $16.50 | 2022 | |
| Amgen INC. | $11.17 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arashk Motiei listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.